← Snapshot 21

Orange Book snapshot 21: Products

Products page 36 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
1752A079019003ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEGLENMARK PHARMS LTD25MGAB["AB"]2017-05-30May 30, 2017NoNoNoRXGLENMARK PHARMACEUTICALS LTD08daf74d85692528771ad84f2464875c4de23f7ebf89b07c08b9648ac66499fa
1753A079019004ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEGLENMARK PHARMS LTD40MGAB["AB"]2017-05-30May 30, 2017NoNoNoRXGLENMARK PHARMACEUTICALS LTD8061226cfc6af7b724b225b575dd05ed98128818ecadc7ec7e4390540468068e
1754A079019005ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEGLENMARK PHARMS LTD60MGAB["AB"]2017-05-30May 30, 2017NoNoNoRXGLENMARK PHARMACEUTICALS LTD4995f62c7a31b55ba88d8909cfedccfcac72e706187ec939354263356bf3b8c8
1755A079019006ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEGLENMARK PHARMS LTD80MGAB["AB"]2017-05-30May 30, 2017NoNoNoRXGLENMARK PHARMACEUTICALS LTD478f019e9b6c938c5534d6a47ca9ac0ba399f66070a686d3815e493aad4c40a2
1756A079019007ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEGLENMARK PHARMS LTD100MGAB["AB"]2017-05-30May 30, 2017NoNoNoRXGLENMARK PHARMACEUTICALS LTD9db4ca6684540ec279692c686bff436a5299262ce66ff176017e1067fa85e394
1757A202682001ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEHETERO LABS LTD V10MGAB["AB"]2021-03-11Mar 11, 2021NoNoNoRXHETERO LABS LTD UNIT V2ebb44290b3f89e938b8f15895857f3b02053f9899041fc2cf18f2375fc54a2a
1758A202682002ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEHETERO LABS LTD V18MGAB["AB"]2021-03-11Mar 11, 2021NoNoNoRXHETERO LABS LTD UNIT V8f8e1f2ba50a11237702ccc37a4b35a61d5d98e993e419890eb1ba32a4b7c8a5
1759A202682003ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEHETERO LABS LTD V25MGAB["AB"]2021-03-11Mar 11, 2021NoNoNoRXHETERO LABS LTD UNIT Vbbd7323b5fa8b240c56d45f4deb6c37d34a2b0679e895cbd713fc0cfcd7df06e
1760A202682004ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEHETERO LABS LTD V40MGAB["AB"]2021-03-11Mar 11, 2021NoNoNoRXHETERO LABS LTD UNIT Veb8b06d1ae0ec813f9a1a548ff5a1f454d3261025de48d66aacb95e6995aaecb
1761A202682005ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEHETERO LABS LTD V60MGAB["AB"]2021-03-11Mar 11, 2021NoNoNoRXHETERO LABS LTD UNIT Vda2fe6a82a5f0aaf7427d4ec50417bc01d6fcf2ee3ca6c5275a9b63e714b9f36
1762A202682006ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEHETERO LABS LTD V80MGAB["AB"]2021-03-11Mar 11, 2021NoNoNoRXHETERO LABS LTD UNIT V93ded5273efcf41893cac6fb609bfca5ff507728c35284f4c8d337b601178e4a
1763A202682007ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEHETERO LABS LTD V100MGAB["AB"]2021-03-11Mar 11, 2021NoNoNoRXHETERO LABS LTD UNIT V7fda25708a88e43e5e2b6da1d5b9afe0ac5863c1300afe903958a3cd96df6e63
1764A079021001ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEMYLAN10MG[]2021-02-18Feb 18, 2021NoNoNoDISCNMYLAN PHARMACEUTICALS INC A VIATRIS CO2bb92d0c030a4a204e4a7cc6b2a8c51d88fb1ad48e215fa7b7983dd41fc45527
1765A079021002ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEMYLAN18MG[]2021-02-18Feb 18, 2021NoNoNoDISCNMYLAN PHARMACEUTICALS INC A VIATRIS COd501dbf020930da37840ca0a71cb6a2a7faaa2150743ba15b13e6005fdfa1c3b
1766A079021003ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEMYLAN25MG[]2021-02-18Feb 18, 2021NoNoNoDISCNMYLAN PHARMACEUTICALS INC A VIATRIS CO705a008e2c9f111e2a8b367157fcd9151c7552ddc2b11c827be2b5cf0b8b8021
1767A079021004ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEMYLAN40MG[]2021-02-18Feb 18, 2021NoNoNoDISCNMYLAN PHARMACEUTICALS INC A VIATRIS CO8549d411edfddfb8e4923a201811263ebd1cf84995be1c45f3591f330f2dddd1
1768A079021005ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEMYLAN60MG[]2021-02-18Feb 18, 2021NoNoNoDISCNMYLAN PHARMACEUTICALS INC A VIATRIS CO46ae8e91fe0cea005d08a9e21829901cba42e64da5477db317ef1c9e92b0ab99
1769A079021006ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEMYLAN80MG[]2021-02-18Feb 18, 2021NoNoNoDISCNMYLAN PHARMACEUTICALS INC A VIATRIS COf46c19b699620c37d3f9c83bae03d41e1ddcb7f74fc40893b2ad0910cac90020
1770A079021007ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEMYLAN100MG[]2021-02-18Feb 18, 2021NoNoNoDISCNMYLAN PHARMACEUTICALS INC A VIATRIS CO2350771127085d7b6fe0db376a21a0fb8006636046d80de81456e17e2863cf42
1771A079022001ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDETEVA PHARMS USA10MGAB["AB"]2017-05-30May 30, 2017NoNoNoRXTEVA PHARMACEUTICALS USAd510007cebcb79a09423d05a255ea2acf76fe166b98d0edf125c29739b1d4fb5
1772A079022002ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDETEVA PHARMS USA18MGAB["AB"]2017-05-30May 30, 2017NoNoNoRXTEVA PHARMACEUTICALS USAd165cfb1ec3f8be500c63333d4084e3798fe0d155635bc0c3af4a254fd72b20c
1773A079022003ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDETEVA PHARMS USA25MGAB["AB"]2017-05-30May 30, 2017NoNoNoRXTEVA PHARMACEUTICALS USA06a3795c4153cef3a869207d13831ad53dfac8367a9582a14a86594547de7362
1774A079022004ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDETEVA PHARMS USA40MGAB["AB"]2017-05-30May 30, 2017NoNoNoRXTEVA PHARMACEUTICALS USA55d618f930c6703311ebc1d5f62d93d358ada2f164c6c1e1962044260aef0bac
1775A079022005ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDETEVA PHARMS USA60MGAB["AB"]2017-05-30May 30, 2017NoNoNoRXTEVA PHARMACEUTICALS USA02af7995c2384110408c8036a25d00e1fab996b9678747a1702b875d69d2dc7f
1776A079022006ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDETEVA PHARMS USA80MGAB["AB"]2017-05-30May 30, 2017NoNoNoRXTEVA PHARMACEUTICALS USAe275bee601f08dbc416638c36aa003563c9368e370cf8869a4a7d53ec2099bcd
1777A079022007ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDETEVA PHARMS USA100MGAB["AB"]2017-05-30May 30, 2017NoNoNoRXTEVA PHARMACEUTICALS USAfe6c9f67ae4d45d2e82fe586a3364d230fd725fe676015ed38a3924f0ff62f2e
1778A079017001ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEZYDUS PHARMS USA INC18MGAB["AB"]2010-09-17Sep 17, 2010NoNoNoRXZYDUS PHARMACEUTICALS USA INCb9941fb9addf26dfac9e64d1400161b62e02601ccd391393b709af303add96e6
1779A079017002ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEZYDUS PHARMS USA INC25MGAB["AB"]2010-09-17Sep 17, 2010NoNoNoRXZYDUS PHARMACEUTICALS USA INC12948addb3cf36d962abac132852310781151e909ae10850c0478889eb727902
1780A079017003ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEZYDUS PHARMS USA INC40MGAB["AB"]2010-09-17Sep 17, 2010NoNoNoRXZYDUS PHARMACEUTICALS USA INC3b2d51f5d821e49fac4f867e8802be01e69576ee4fb6e19ed285778fe27f2e22
1781A079017004ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEZYDUS PHARMS USA INC60MGAB["AB"]2010-09-17Sep 17, 2010NoNoNoRXZYDUS PHARMACEUTICALS USA INC6269a7df4bc9f4a817215f31a8c4035e63d4193fd7226282e9ac15b3f0d01241
1782A079017005ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEZYDUS PHARMS USA INC80MGAB["AB"]2010-09-17Sep 17, 2010NoNoNoRXZYDUS PHARMACEUTICALS USA INC7bb242c71e1a0a11c7d6f9c97e26d917ed9e311d7a58ce39c219063c518cb62d
1783A079017006ATOMOXETINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALATOMOXETINE HYDROCHLORIDEZYDUS PHARMS USA INC100MGAB["AB"]2010-09-17Sep 17, 2010NoNoNoRXZYDUS PHARMACEUTICALS USA INC394a9e8659a4734d407a7a85910234dd085f41fa00eb4d3ee496ea67b8f0bd85
1784N016099002CLOFIBRATECAPSULE;ORALCAPSULEORALATROMID-SWYETH AYERST500MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNWYETH AYERST LABORATORIES572b106d03dd809ede0b982e847a8e228172735cb62669b99319a87aad1ea55d
1785N014684001NORTRIPTYLINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALAVENTYL HYDROCHLORIDELILLYEQ 10MG BASE[]Approved Prior to Jan 1, 1982YesNoNoDISCNELI LILLY AND CO34e348c5ca1276fde127cbcefd7b7276d040fff0d5529e33c4ee7bed120d3131
1786N014684002NORTRIPTYLINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALAVENTYL HYDROCHLORIDELILLYEQ 25MG BASE[]Approved Prior to Jan 1, 1982YesNoNoDISCNELI LILLY AND COa003a9dea0d6fda40d83d33cb41d80d4b3016a968e509a561a8cbf8e46beff3d
1787N021319001DUTASTERIDECAPSULE;ORALCAPSULEORALAVODARTGLAXOSMITHKLINE0.5MGAB["AB"]2001-11-20Nov 20, 2001NoYesYesRXGLAXOSMITHKLINEb0104b4338815831d0578d4591570661939cf866a05e1fb8e28bd732c02f20fa
1788N019508001NIZATIDINECAPSULE;ORALCAPSULEORALAXIDSMITHKLINE BEECHAM150MG[]1988-04-12Apr 12, 1988NoNoNoDISCNSMITHKLINE BEECHAM CORP DBA GLAXOSMITHKLINEae150e83c43ce5b7a32ab97194292b802c505bbfad7baca0665a30a2221f8152
1789N019508002NIZATIDINECAPSULE;ORALCAPSULEORALAXIDSMITHKLINE BEECHAM300MG[]1988-04-12Apr 12, 1988NoNoNoDISCNSMITHKLINE BEECHAM CORP DBA GLAXOSMITHKLINEf24d5e586dff3fbbed3eac4e97a67e8788e08fc72a036f3f413bfe68fb59f94f
1790A087260001PHENYLBUTAZONECAPSULE;ORALCAPSULEORALAZOLIDSANOFI AVENTIS US100MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNSANOFI AVENTIS US LLCf0c103b0f65f348c6008f374c2002c3b90eff27b055f82b4cca1b9a1bfaaea05
1791A061336001OXACILLIN SODIUMCAPSULE;ORALCAPSULEORALBACTOCILLGLAXOSMITHKLINEEQ 250MG BASE[]Approved Prior to Jan 1, 1982YesNoNoDISCNGLAXOSMITHKLINE9bdb77cf135a7c19c9a7162d23bd22c3336b703f08e50c58033a8fc2ffab115a
1792A062241001OXACILLIN SODIUMCAPSULE;ORALCAPSULEORALBACTOCILLGLAXOSMITHKLINEEQ 250MG BASE[]Approved Prior to Jan 1, 1982YesNoNoDISCNGLAXOSMITHKLINEeb828d94ac3a49f286ec45935ba94ef8e0d8233c3abd428df6fe30a0bcc6110c
1793A061336002OXACILLIN SODIUMCAPSULE;ORALCAPSULEORALBACTOCILLGLAXOSMITHKLINEEQ 500MG BASE[]Approved Prior to Jan 1, 1982YesNoNoDISCNGLAXOSMITHKLINE3dfdbdbf633c4f69e5551544fca31add673620c0027e8e3708302e6736da5dd3
1794A062241002OXACILLIN SODIUMCAPSULE;ORALCAPSULEORALBACTOCILLGLAXOSMITHKLINEEQ 500MG BASE[]Approved Prior to Jan 1, 1982YesNoNoDISCNGLAXOSMITHKLINE0677bb4ed94578ab32c75453d426135e35181a6c810e727c27b5480391073bc2
1795A077883001BALSALAZIDE DISODIUMCAPSULE;ORALCAPSULEORALBALSALAZIDE DISODIUMAPOTEX INC750MGAB["AB"]2007-12-28Dec 28, 2007NoNoNoRXAPOTEX INC ETOBICOKE SITE9e610266a31a47e53c25b38e41eb690f2dd1312bf8bda09c998ae6135728bbb2
1796A077806001BALSALAZIDE DISODIUMCAPSULE;ORALCAPSULEORALBALSALAZIDE DISODIUMHIKMA750MGAB["AB"]2007-12-28Dec 28, 2007NoNoNoRXHIKMA PHARMACEUTICALS USA INCc6e82919f3aaf2e635e09e4bc823cffd19ae0f68b6e64f01555125a208367d36
1797A077807001BALSALAZIDE DISODIUMCAPSULE;ORALCAPSULEORALBALSALAZIDE DISODIUMMYLAN750MG[]2007-12-28Dec 28, 2007NoNoNoDISCNMYLAN PHARMACEUTICALS INCd67a49a001c99424090c2ee12e8b7f669362ec9822e22ea307482bf24e209458
1798A088889001ACETAMINOPHEN; BUTALBITALCAPSULE;ORALCAPSULEORALBANCAPFOREST PHARMS325MG;50MG[]1986-01-16Jan 16, 1986NoNoNoDISCNFOREST PHARMACEUTICALS INC99f85770857e3e76bbe7ece1dc2c37ca3872f942028a6c2231d9787c1018a295
1799A087961001ACETAMINOPHEN; HYDROCODONE BITARTRATECAPSULE;ORALCAPSULEORALBANCAP HCFOREST PHARMS500MG;5MG[]1983-03-17Mar 17, 1983NoNoNoDISCNFOREST PHARMACEUTICALS INC86aae034124dd7abe18cc26c2d682be8c2196441e49e8a5b3515d89f0e477190
1800N005845007DIPHENHYDRAMINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALBENADRYLMCNEIL CONS25MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNMCNEIL CONSUMER HEALTHCARE957c0d4f5d409ad9f14485e4907b011791e162529f0a5dff4f2de12a5961818e
1801N005845001DIPHENHYDRAMINE HYDROCHLORIDECAPSULE;ORALCAPSULEORALBENADRYLMCNEIL CONS50MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNMCNEIL CONSUMER HEALTHCARE26b285b8ee451c8f564ebcb600272a21f72beae9e6fb8e6c0aa4eb43df1dd4ad